Reduction of Plasma Gonadotropin Levels and Pituitary Tumor Size by Treatment with Bromocriptine in a Patient with Gonadotropinoma
| Autor: | Noriyoshi Yamakita, Toshihiro Murai, Takashi Komaki, Satoru Kawamura |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
Adenoma
Male endocrine system Pituitary gland medicine.medical_specialty endocrine system diseases medicine.drug_class Follicle-stimulating hormone Internal medicine Internal Medicine medicine Humans Pituitary Neoplasms Bromocriptine Testosterone Aged business.industry Pituitary tumors General Medicine medicine.disease Magnetic Resonance Imaging medicine.anatomical_structure Endocrinology Dopamine Agonists Gonadotropins Pituitary Gonadotropin Luteinizing hormone business hormones hormone substitutes and hormone antagonists Follow-Up Studies medicine.drug |
| Zdroj: | Internal Medicine. 38:266-271 |
| ISSN: | 1349-7235 0918-2918 |
| DOI: | 10.2169/internalmedicine.38.266 |
| Popis: | A pituitary tumor with suprasellar extension was found by magnetic resonance imaging (MRI) in a male with diabetes mellitus. Endocrine examination revealed high plasma follicle-stimulating hormone (FSH) and alpha-subunit levels, which increased with administration of thyrotropin (TSH)-releasing hormone (TRH). Plasma luteinizing hormone (LH) and testosterone levels were low. Pituitary gonadotropin producing tumor was diagnosed. Because the patient refused surgery, bromocriptine was administered and plasma FSH and alpha-subunit rapidly decreased; on MRI the tumor size was gradually reduced. When pituitary operation is not feasible, bromocriptine is one choice of treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|